Curcumin, a polyphenolic compound derived from Curcuma longa, has shown extensive antimicrobial, antiviral, and antifungal activities. This review summarizes the current research on curcumin's antimicrobial properties, highlighting its potential as a natural antimicrobial agent. Curcumin exhibits broad-spectrum antimicrobial activity against bacteria, viruses, fungi, and parasites. It has been shown to inhibit the growth of various bacteria, including Staphylococcus aureus, Escherichia coli, and Bacillus subtilis, with MIC values ranging from 4 to 16 g/L. Curcumin also demonstrates antifungal activity against fungi such as Cryptococcus neoformans, Candida albicans, and Paracoccidioides brasiliensis. In addition, curcumin has antiviral effects against various viruses, including HIV-1, herpes simplex virus, influenza, and coxsackievirus. It inhibits viral replication by targeting viral enzymes and pathways, such as HIV-1 integrase and the viral transcription process. Curcumin also shows potential in reducing inflammation and oxidative stress associated with viral infections. Curcumin's antimicrobial activity is enhanced through synergistic effects with other antimicrobial agents, such as antibiotics and antifungal drugs. It has been shown to work synergistically with ampicillin, ciprofloxacin, and other antibiotics against Staphylococcus aureus and other bacteria. Additionally, curcumin has been found to inhibit biofilm formation by Pseudomonas aeruginosa, which is a significant challenge in treating infections. Curcumin's antifungal activity is attributed to its ability to inhibit the growth of Candida species and other fungi by disrupting fungal cell membranes and reducing the production of ergosterol. To improve curcumin's bioavailability and solubility, various formulations have been developed, including curcumin-loaded nanoparticles, microcapsules, and nanocurcumin. These formulations enhance curcumin's cellular uptake and bioavailability, leading to improved antimicrobial activity. Despite its promising antimicrobial properties, curcumin's clinical application is still under investigation, with ongoing clinical trials for various diseases, including cancer, Alzheimer's, and psoriasis. Overall, curcumin shows significant potential as a natural antimicrobial agent with broad applications in medicine and healthcare.Curcumin, a polyphenolic compound derived from Curcuma longa, has shown extensive antimicrobial, antiviral, and antifungal activities. This review summarizes the current research on curcumin's antimicrobial properties, highlighting its potential as a natural antimicrobial agent. Curcumin exhibits broad-spectrum antimicrobial activity against bacteria, viruses, fungi, and parasites. It has been shown to inhibit the growth of various bacteria, including Staphylococcus aureus, Escherichia coli, and Bacillus subtilis, with MIC values ranging from 4 to 16 g/L. Curcumin also demonstrates antifungal activity against fungi such as Cryptococcus neoformans, Candida albicans, and Paracoccidioides brasiliensis. In addition, curcumin has antiviral effects against various viruses, including HIV-1, herpes simplex virus, influenza, and coxsackievirus. It inhibits viral replication by targeting viral enzymes and pathways, such as HIV-1 integrase and the viral transcription process. Curcumin also shows potential in reducing inflammation and oxidative stress associated with viral infections. Curcumin's antimicrobial activity is enhanced through synergistic effects with other antimicrobial agents, such as antibiotics and antifungal drugs. It has been shown to work synergistically with ampicillin, ciprofloxacin, and other antibiotics against Staphylococcus aureus and other bacteria. Additionally, curcumin has been found to inhibit biofilm formation by Pseudomonas aeruginosa, which is a significant challenge in treating infections. Curcumin's antifungal activity is attributed to its ability to inhibit the growth of Candida species and other fungi by disrupting fungal cell membranes and reducing the production of ergosterol. To improve curcumin's bioavailability and solubility, various formulations have been developed, including curcumin-loaded nanoparticles, microcapsules, and nanocurcumin. These formulations enhance curcumin's cellular uptake and bioavailability, leading to improved antimicrobial activity. Despite its promising antimicrobial properties, curcumin's clinical application is still under investigation, with ongoing clinical trials for various diseases, including cancer, Alzheimer's, and psoriasis. Overall, curcumin shows significant potential as a natural antimicrobial agent with broad applications in medicine and healthcare.